These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33843527)

  • 1. Acceptability and effectiveness of antimicrobial stewardship implementation strategies on fluoroquinolone prescribing.
    Suda KJ; Clore GS; Evans CT; Reisinger HS; Kale I; Echevarria K; Sherlock SH; Perencevich EN; Goetz MB;
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1361-1368. PubMed ID: 33843527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi T; Conlon A; Chopra V; Malani AN; Flanders SA
    Clin Infect Dis; 2019 Sep; 69(8):1269-1277. PubMed ID: 30759198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inpatient Fluoroquinolone Stewardship Improves the Quantity and Quality of Fluoroquinolone Prescribing at Hospital Discharge: A Retrospective Analysis Among 122 Veterans Health Administration Hospitals.
    Suzuki H; Perencevich EN; Alexander B; Beck BF; Goto M; Lund BC; Nair R; Livorsi DJ
    Clin Infect Dis; 2020 Aug; 71(5):1232-1239. PubMed ID: 31562815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
    Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department.
    Borde JP; Kern WV; Hug M; Steib-Bauert M; de With K; Busch HJ; Kaier K
    Emerg Med J; 2015 Jul; 32(7):509-15. PubMed ID: 25261006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation and Perceived Effectiveness of Prospective Audit and Feedback and Preauthorization by US Pediatric Antimicrobial Stewardship Programs.
    Manice CS; Muralidhar N; Campbell JI; Nakamura MM
    J Pediatric Infect Dis Soc; 2024 Feb; 13(2):117-122. PubMed ID: 38109895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a successful fluoroquinolone restriction intervention among high-risk patients: A mixed-methods study.
    Tischendorf J; Brunner M; Knobloch MJ; Schulz L; Barker A; Wright MO; Lepak A; Safdar N
    PLoS One; 2020; 15(8):e0237987. PubMed ID: 32841259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study.
    Hernandez-Santiago V; Davey PG; Nathwani D; Marwick CA; Guthrie B
    PLoS Med; 2019 Jun; 16(6):e1002825. PubMed ID: 31173597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise Expansion of Antimicrobial Stewardship Programs and Its Impact on Antibiotic Use and Resistance Rates at a Tertiary Care Hospital in Korea.
    Shin DH; Kim HS; Heo E; Shin MJ; Kim NH; Lee H; Park JS; Park KU; Jung J; Song KH; Kang M; Jung J; Kim ES; Kim HB
    Microbiol Spectr; 2022 Jun; 10(3):e0033522. PubMed ID: 35467411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The feasibility of implementing antibiotic restrictions for fluoroquinolones and cephalosporins: a mixed-methods study across 15 Veterans Health Administration hospitals.
    Livorsi DJ; Suda KJ; Cunningham Goedken C; Hockett Sherlock S; Balkenende E; Chasco EE; Scherer AM; Goto M; Perencevich EN; Goetz MB; Reisinger HS;
    J Antimicrob Chemother; 2021 Jul; 76(8):2195-2203. PubMed ID: 34015115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Nonrestrictive Approach to Fluoroquinolone Stewardship at Two Community Hospitals.
    Truong WR; Robinson PA; Beuttler RC; Yamaki J
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac388. PubMed ID: 36004311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Fluoroquinolone Prescribing Rates With Black Box Warnings from the US Food and Drug Administration.
    Sankar A; Swanson KM; Zhou J; Jena AB; Ross JS; Shah ND; Karaca-Mandic P
    JAMA Netw Open; 2021 Dec; 4(12):e2136662. PubMed ID: 34851398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial stewardship intervention bundle decreases outpatient fluoroquinolone prescribing for urinary tract infections.
    Cubillos AL; Patch ME; Chandler EL; Lynch LW; Gieselman MR; Saunders MB; Calkins KE
    Infect Control Hosp Epidemiol; 2023 Mar; 44(3):488-490. PubMed ID: 35403600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing Fluoroquinolone Use and Clostridioides difficile Infections in Community Nursing Homes Through Hospital-Nursing Home Collaboration.
    Felsen CB; Dodds Ashley ES; Barney GR; Nelson DL; Nicholas JA; Yang H; Aydelotte ME; Karlic A; Nicholas NC; Petrone KK; Pine RD; Schabel SL; Medina-Walpole A; Dumyati GK
    J Am Med Dir Assoc; 2020 Jan; 21(1):55-61.e2. PubMed ID: 31888865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework.
    Vaughn VM; Ratz D; Greene MT; Flanders SA; Gandhi TN; Petty LA; Huls S; Feng X; White AT; Hersh AL
    Clin Infect Dis; 2022 Sep; 75(6):1063-1072. PubMed ID: 35143638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of syndrome-specific antimicrobial stewardship interventions on use of and resistance to fluoroquinolones: An interrupted time series analysis.
    Hecker MT; Son AH; Murphy NN; Sethi AK; Wilson BM; Watkins RR; Donskey CJ
    Am J Infect Control; 2019 Aug; 47(8):869-875. PubMed ID: 30850252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The devil's in the defaults: An interrupted time-series analysis of the impact of default duration elimination on exposure to fluoroquinolone therapy.
    Wrenn RH; Slaton CN; Diez T; Turner NA; Yarrington ME; Anderson DJ; Moehring RW
    Infect Control Hosp Epidemiol; 2024 Jun; 45(6):733-739. PubMed ID: 38347810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a Collaborative, Community Hospital Network for Antimicrobial Stewardship Program Implementation.
    Moehring RW; Yarrington ME; Davis AE; Dyer AP; Johnson MD; Jones TM; Spires SS; Anderson DJ; Sexton DJ; Dodds Ashley ES
    Clin Infect Dis; 2021 Nov; 73(9):1656-1663. PubMed ID: 33904897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
    Kuehn R; Stoesser N; Eyre D; Darton TC; Basnyat B; Parry CM
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD010452. PubMed ID: 36420914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.